Exact Mass: 529.3111

Exact Mass Matches: 529.3111

Found 74 metabolites which its exact mass value is equals to given mass value 529.3111, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

LysoPE(0:0/22:4(7Z,10Z,13Z,16Z))

(2-aminoethoxy)[(2R)-2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-hydroxypropoxy]phosphinic acid

C27H48NO7P (529.3168)


LysoPE(0:0/22:4(7Z,10Z,13Z,16Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/22:4(7Z,10Z,13Z,16Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

LysoPE(22:4(7Z,10Z,13Z,16Z)/0:0)

(2-aminoethoxy)[(2R)-3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-2-hydroxypropoxy]phosphinic acid

C27H48NO7P (529.3168)


LysoPE(22:4(7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(22:4(7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

(5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoylcarnitine

3-({7-[3-hydroxy-2-(3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl]hept-5-enoyl}oxy)-4-(trimethylazaniumyl)butanoate

C30H43NO7 (529.3039)


(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoylcarnitine is an acylcarnitine. More specifically, it is an (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Phosphatidylethanolamine lyso 22:4

Phosphatidylethanolamine lyso 22:4

C27H48NO7P (529.3168)


   

4-O-(alpha-L-arabinopyranosyl) nervogenic acid lindelofidine ester|nervosine I

4-O-(alpha-L-arabinopyranosyl) nervogenic acid lindelofidine ester|nervosine I

C30H43NO7 (529.3039)


   

leopolic acid A

leopolic acid A

C29H43N3O6 (529.3152)


   

Leu Gly Asp Val Ile

Leu Gly Asp Val Ile

C24H43N5O8 (529.3111)


   

Ala Gln Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C20H39N11O6 (529.3085)


   

Ala Arg Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C20H39N11O6 (529.3085)


   

Ala Arg Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C20H39N11O6 (529.3085)


   

Phe His Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanoic acid

C26H39N7O5 (529.3013)


   

Phe His Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]hexanoic acid

C26H39N7O5 (529.3013)


   

Phe Lys His Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C26H39N7O5 (529.3013)


   

Phe Lys Val His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H39N7O5 (529.3013)


   

Phe Val His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C26H39N7O5 (529.3013)


   

Phe Val Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H39N7O5 (529.3013)


   

His Phe Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]hexanamido]-3-methylbutanoic acid

C26H39N7O5 (529.3013)


   

His Phe Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]hexanoic acid

C26H39N7O5 (529.3013)


   

His Lys Phe Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C26H39N7O5 (529.3013)


   

His Lys Val Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C26H39N7O5 (529.3013)


   

His Val Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]hexanoic acid

C26H39N7O5 (529.3013)


   

His Val Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]hexanamido]-3-phenylpropanoic acid

C26H39N7O5 (529.3013)


   

Lys Phe His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C26H39N7O5 (529.3013)


   

Lys Phe Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H39N7O5 (529.3013)


   

Lys His Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C26H39N7O5 (529.3013)


   

Lys His Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C26H39N7O5 (529.3013)


   

Lys Val Phe His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H39N7O5 (529.3013)


   

Lys Val His Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C26H39N7O5 (529.3013)


   

Gln Ala Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C20H39N11O6 (529.3085)


   

Gln Arg Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]propanamido]-5-carbamimidamidopentanoic acid

C20H39N11O6 (529.3085)


   

Gln Arg Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]propanoic acid

C20H39N11O6 (529.3085)


   

Arg Ala Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C20H39N11O6 (529.3085)


   

Arg Ala Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C20H39N11O6 (529.3085)


   

Arg Gln Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]propanamido]-5-carbamimidamidopentanoic acid

C20H39N11O6 (529.3085)


   

Arg Gln Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]propanoic acid

C20H39N11O6 (529.3085)


   

Arg Arg Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]propanamido]-4-carbamoylbutanoic acid

C20H39N11O6 (529.3085)


   

Arg Arg Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]propanoic acid

C20H39N11O6 (529.3085)


   

Val Phe His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C26H39N7O5 (529.3013)


   

Val Phe Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H39N7O5 (529.3013)


   

Val His Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]hexanoic acid

C26H39N7O5 (529.3013)


   

Val His Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-phenylpropanoic acid

C26H39N7O5 (529.3013)


   

Val Lys Phe His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H39N7O5 (529.3013)


   

Val Lys His Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C26H39N7O5 (529.3013)


   

LPE(22:4)

(7Z,10Z,13Z,16Z-Docosatetraenoyl)-lysophosphatidylethanolamine

C27H48NO7P (529.3168)


   

LysoPE(22:4/0:0)

(2-aminoethoxy)[(2R)-3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-2-hydroxypropoxy]phosphinic acid

C27H48NO7P (529.3168)


   

LPE 22:4

2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine

C27H48NO7P (529.3168)


   

N-methyltaurocholic acid

3α,7α,12α-trihydroxy-5β-cholan-24-oyl-N-methyltaurine

C27H47NO7S (529.3073)


   

(5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoylcarnitine

(5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoylcarnitine

C30H43NO7 (529.3039)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C27H48NO7P (529.3168)


   

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C27H48NO7P (529.3168)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] hexanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] hexanoate

C27H48NO7P (529.3168)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] butanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] butanoate

C27H48NO7P (529.3168)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] acetate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propan-2-yl] acetate

C27H48NO7P (529.3168)


   
   

LysoPE(0:0/22:4(7Z,10Z,13Z,16Z))

LysoPE(0:0/22:4(7Z,10Z,13Z,16Z))

C27H48NO7P (529.3168)


   

LPE(22:4(7Z,10Z,13Z,16Z)/0:0)

LPE(22:4(7Z,10Z,13Z,16Z)/0:0)

C27H48NO7P (529.3168)


   

PE(22:4/0:0)

PE(22:4/0:0)

C27H48NO7P (529.3168)


A lysophosphatidylethanolamine 22:4 in which the acyl group is located at position 1.

   

PE(22:4)

PE(8:0(1)_14:4)

C27H48NO7P (529.3168)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

LdMePE(20:4)

LdMePE(20:4)

C27H48NO7P (529.3168)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MePC(18:4)

MePC(8:0(1)_10:4)

C27H48NO7P (529.3168)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC(19:4)

PC(8:0(1)_11:4)

C27H48NO7P (529.3168)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   

PE P-22:3 or PE O-22:4

PE P-22:3 or PE O-22:4

C27H48NO7P (529.3168)


   

ST 28:5;O5;Gly

ST 28:5;O5;Gly

C30H43NO7 (529.3039)


   

ST 22:4;O2;HexNAc

ST 22:4;O2;HexNAc

C30H43NO7 (529.3039)


   
   

2-{n-[1-(4-decyl-3-hydroxy-2-oxo-5h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

2-{n-[1-(4-decyl-3-hydroxy-2-oxo-5h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

C29H43N3O6 (529.3152)


   

(2s)-2-{n-[(2s)-1-(4-decyl-3-hydroxy-2-oxo-5h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

(2s)-2-{n-[(2s)-1-(4-decyl-3-hydroxy-2-oxo-5h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-(c-hydroxycarbonimidoyl)amino}-3-phenylpropanoic acid

C29H43N3O6 (529.3152)